<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-10T13:19:09+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>疫苗之王退位，是辉瑞的接班人继任，还是默沙东上位？</title>
    <updated>2020-12-10T12:17:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/EuUf4YagMvY56RIHXKrbaQ</id>
    <link href="https://mp.weixin.qq.com/s/EuUf4YagMvY56RIHXKrbaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“神药”还需“神原料”|AB水解物提高抗体和病毒的产量</title>
    <updated>2020-12-10T12:17:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/t8XcLEeit4_stcJr2Y1xMw</id>
    <link href="https://mp.weixin.qq.com/s/t8XcLEeit4_stcJr2Y1xMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新型免疫调节剂BNZ-1对IL-2、IL-9和IL-15的联合抑制作用</title>
    <updated>2020-12-10T12:17:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/5h6xJ8KVEU3G0lCny-EGNg</id>
    <link href="https://mp.weixin.qq.com/s/5h6xJ8KVEU3G0lCny-EGNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关键时刻被爆出问题！辉瑞新冠疫苗可能导致面瘫</title>
    <updated>2020-12-10T12:17:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/V5H8ShszKIFisYJdBhFz9Q</id>
    <link href="https://mp.weixin.qq.com/s/V5H8ShszKIFisYJdBhFz9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IPO | 和铂医药今日港股上市，开跌3.5%</title>
    <updated>2020-12-10T12:17:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/hYK5sXN0zVgK8BfEUWT4AA</id>
    <link href="https://mp.weixin.qq.com/s/hYK5sXN0zVgK8BfEUWT4AA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【佰家言】生物药背后的战场 | 健顺生物罗顺博士专访</title>
    <updated>2020-12-09T11:31:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/AQDUCALNISeaWPe0lD_f8g</id>
    <link href="https://mp.weixin.qq.com/s/AQDUCALNISeaWPe0lD_f8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年创新药物临床前研究学术进展报告</title>
    <updated>2020-12-09T11:31:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/uH8jE_tsA9MPATTXIvLLEQ</id>
    <link href="https://mp.weixin.qq.com/s/uH8jE_tsA9MPATTXIvLLEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PI3Kα抑制剂的研发进展与反思</title>
    <updated>2020-12-09T11:31:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/rmY3VLxA8DTnxWqo-wCctQ</id>
    <link href="https://mp.weixin.qq.com/s/rmY3VLxA8DTnxWqo-wCctQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科济生物CT053全人抗BCMA自体CAR T细胞注射液纳入突破性治疗药物品种，用于治疗复发难治性多发性骨髓瘤</title>
    <updated>2020-12-09T11:31:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Tu1r2wpt8V2MHNxx_YbkCQ</id>
    <link href="https://mp.weixin.qq.com/s/Tu1r2wpt8V2MHNxx_YbkCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH: 时隔一年， CD20xCD3双抗疗效仍然惊艳</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/He1s2NRVctJq2OHZ_Tby3w</id>
    <link href="https://mp.weixin.qq.com/s/He1s2NRVctJq2OHZ_Tby3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>柳叶刀：PD-1之后，膀胱癌患者有望迎来基因疗法</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/5pX2ftbGG7_DaVtnCKp_cQ</id>
    <link href="https://mp.weixin.qq.com/s/5pX2ftbGG7_DaVtnCKp_cQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>间充质干细胞调节免疫和治疗工艺开发</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/tR9-xXR5dMumSSwGtvZvkA</id>
    <link href="https://mp.weixin.qq.com/s/tR9-xXR5dMumSSwGtvZvkA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>雇佣条款未决争议，康宁杰瑞解聘CFO</title>
    <updated>2020-12-08T11:20:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/CG9VeBCSMFzU2AOs4kbMkg</id>
    <link href="https://mp.weixin.qq.com/s/CG9VeBCSMFzU2AOs4kbMkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>License in 变质了吗？</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/-hP1tUI2SNrW7k6pl-CcIw</id>
    <link href="https://mp.weixin.qq.com/s/-hP1tUI2SNrW7k6pl-CcIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>网络直播 | 运用新型抗体文库开发针对几乎所有靶点的治疗药物</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/HcsZpPJSqWmbYypslQ11UA</id>
    <link href="https://mp.weixin.qq.com/s/HcsZpPJSqWmbYypslQ11UA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠年终盘点：我们与COVID-19共处的这一年</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/JoFxwuI-i8Bbgsq3qtwxXA</id>
    <link href="https://mp.weixin.qq.com/s/JoFxwuI-i8Bbgsq3qtwxXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>沃森又不卖泽润了！原来爱情还可以抢救一下</title>
    <updated>2020-12-07T18:35:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/TFEY0ZtQMLymJYlur2vtcA</id>
    <link href="https://mp.weixin.qq.com/s/TFEY0ZtQMLymJYlur2vtcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Bio-ONE精彩回顾 | 生物医药新型工艺大会是如何炼成的？</title>
    <updated>2020-12-06T16:00:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/jc316qSu9IDC5IXHR13O4Q</id>
    <link href="https://mp.weixin.qq.com/s/jc316qSu9IDC5IXHR13O4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶点药讯38|纵览全球药物靶点动态</title>
    <updated>2020-12-06T16:00:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/Dq_LFiExWLv9QhenO7wRrA</id>
    <link href="https://mp.weixin.qq.com/s/Dq_LFiExWLv9QhenO7wRrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“华为本为”正式进入生物药研发领域</title>
    <updated>2020-12-06T16:00:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-06:/s/aDyw-KcufpBRnVFTvqoYuA</id>
    <link href="https://mp.weixin.qq.com/s/aDyw-KcufpBRnVFTvqoYuA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>